ABRC issues 30-Day Notice for the Opening of Request for Grant Applications for the study of Psilocybin Whole Mushrooms

The Arizona Department of Health Services (ADHS), through the Arizona Biomedical Research Centre (ABRC), will be opening a solicitation approximately thirty (30) days from the publication of this notice for the acceptance of grant applications to conduct clinical trials on the efficacy of Psilocybin Whole Mushrooms on various conditions, disorders, and diseases.
This announcement serves as the notice required pursuant to by Laws 2023, Chapter 139 (56th Leg 1st Reg), SB 1726, Sec. 6(B)1

(https://www.azleg.gov/legtext/56leg/1R/laws/0139.pdf).Continue reading

Mayo Clinic and Columbia University receive $10.6 million grant from NCI to advance glioblastoma research with mathematical oncology

National Cancer Institute (NCI) to further study combining the molecular analysis of glioblastoma with MRI.

The center will be based at Mayo Clinic in Arizona with co-principal investigator Peter Canoll, M.D., Ph.D., Columbia University, and involves collaboration among multiple institutions, including Arizona State University, Columbia University, City of Hope, Inova, Mayo Clinic Rochester, MD Anderson and Washington University.Continue reading

CancerX Launches New Startup Accelerator to Advance Digital Innovations in Oncology

TAMPA, Fla. – CancerX, co-hosted by Moffitt Cancer Center and the Digital Medicine Society (DiMe) alongside the Office of the National Coordinator for Health Information Technology and the Office of the Assistant Secretary for Health announced the launch of the CancerX Startup Accelerator today at the Future of Cancer Care Summit in Tampa, Fla. It is the first-ever national cancer innovation accelerator initiative with public support from the White House. 

Continue reading